Document and Entity Information
Document and Entity Information | Nov. 12, 2021 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Nov. 12, 2021 |
Entity Registrant Name | DICE THERAPEUTICS, INC. |
Entity Central Index Key | 0001645569 |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Entity File Number | 001-40794 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 47-2286244 |
Entity Address, Address Line One | 279 E. Grand Avenue |
Entity Address, Address Line Two | Suite 300 |
Entity Address, City or Town | South San Francisco |
Entity Address, State or Province | CA |
Entity Address, Postal Zip Code | 94080 |
City Area Code | 650 |
Local Phone Number | 566-1420 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of each class | Common Stock, $0.0001 Par Value Per Share |
Trading Symbol | DICE |
Name of each exchange on which registered | NASDAQ |